The largest database of trusted experimental protocols

9 protocols using celltiter 96 aqueous assay reagent

1

MTS Cell Viability Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For each compound LC50 was determined using a MTS tetrazolium cell viability assay according to the manufacturer’s instructions (CellTiter 96 AQueous Assay reagent; Promega). Briefly, the CellTiter 96 AQueous One Solution Reagent was added to each well and incubated at 37°C for 3 hr. Cell proliferation was determined by measuring the absorbance at 490 nm using a microtiter plate reader (Molecular Devices, Sunnyvale, CA). The LC50 was obtained from the MTS viability curves using GraphPad Prism 5. Experiments were carried out in triplicate.
+ Open protocol
+ Expand
2

Cell Proliferation Assay Using CellTiter 96® AQ

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded in four replicates at a density of 10,000 cells per well in a 96-well plate. At each time point, 20 μl of CellTiter 96® AQueous Assay reagent (Promega) were added directly to each well with minimal exposure to light. Plates were incubated for 1 h at 37°C, 5 % CO2. Formazan absorption was measured at 490 nm using an Infinite M200 spectrophotometer (Tecan). The mean absorbance of wells was displayed as optical density to estimate proliferation status.
+ Open protocol
+ Expand
3

Measuring BV2 Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability was measured by using the CellTiter 96 AQueous Assay reagent (Promega, Madison, WI, United States) which utilizes the novel tetrazolium compound (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt; MTS) and the electron coupling reagent, phenazine methosulfate (PMS). BV2 cells (1 × 104/well) were plated in 96 well plates and treated with low glucose (LG) (17.5 mM), high glucose (HG) (35 mM), or mannitol (35 mM) or LPS (10 ng/mL). MTS/PMS solutions were added into each well plate containing cell culture medium. The measurement of the absorbance of the formazan was performed at 490 nm.
+ Open protocol
+ Expand
4

MTS Cell Viability Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
MTS tetrazolium cell viability assays were done according to the manufacturer's instructions (CellTiter 96 AQueous Assay reagent; Promega). Briefly, the CellTiter 96 AQueous One Solution Reagent was added to each well and incubated at 37°C for 3 hr. Cell proliferation was determined by measuring the absorbance at 490 nm using a microplate reader (Molecular Devices). The half-maximal inhibitory concentration (IC50) was obtained from the MTS viability curves using GraphPad Prism 5. Experiments were carried out in triplicate.
+ Open protocol
+ Expand
5

Cytotoxicity Evaluation of Complexes on hASCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cytotoxicity of the complexes was evaluated using MTS-based CellTiter 96 AQueous Assay reagent (Promega, Madison, WI, USA) according to manufacturer’s instructions. Briefly hASCs were plated at a density 1 × 104 cells per well in flat-bottomed 96-well plates (Corning Costar, Cambridge, MA, USA) and were incubated at 37 °C. After 24 h, the hASCs were incubated with 4 µL of pDNA/PEI binary complex or 6 µL of pDNA/PEI/HA ternary complexes for 24 or 48 h. For the MTS assay, 10 µL of MTS reagent was added into each well containing 100 µL of culture medium, and then the plates were incubated for 3 h at 37 °C. Absorbance of the wells was detected at 490 nm by a microplate reader (VersaMax, Molecular Devices, Sunnyvale, CA, USA).
+ Open protocol
+ Expand
6

Comprehensive Cell Viability Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
MTS cell survival was measured using the CellTiter 96 Aqueous Assay reagent (Promega, WI, USA). LDH Release was measured using the CytoTox 96 Non-Radioactive reagent (Promega). Plates were recorded at 490 nm and 690 nm (plate background). Cell survival was measured using Red Neutral staining as described previously [59 (link)]. Plates were recorded at 540 nm. Apoptosis was measured with the RealTime-Glo Annexin V Apoptosis Assay (Promega) or with AnnexinV-FITC and propidium iodide (PI) (BioLegend) before flow cytometry analysis (FACSCalibur, BD, NJ, USA) driven by BD CellQuest software (BD). All assays were performed according to manufacturers' instructions.
+ Open protocol
+ Expand
7

MTS Tetrazolium Assay for Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
MTS tetrazolium cell viability assays were done according to the manufacturer’s instructions (CellTiter 96 AQueous Assay reagent; Promega). Briefly, the CellTiter 96 AQueous One Solution Reagent was added to each well and incubated at 37°C for 3 hrs. Cell proliferation was determined by measuring the absorbance at 490 nm using a microtiter plate reader (Molecular Devices, Sunnyvale, CA). The half-maximal inhibitory concentration (IC50) was obtained from the MTS viability curves using GraphPad Prism 5. We chose this parameter in order to normalize the results with different drugs. It was previously demonstrated that the highest rate of HAC loss was observed at the IC50 (8 ). For each drug, the experiments aimed at the detection of the IC50 were carried out in triplicate. These data are presented in Supplementary Table S1.
+ Open protocol
+ Expand
8

Targeting RRM2 and RRM2B for Cancer Invasion

Check if the same lab product or an alternative is used in the 5 most similar protocols
RRM2 and scrambled control siRNA were purchased from Santa Cruz Biotechnology Inc. Cells were seeded at 2 × 105 cells per well in 6-well plates filled with 2 mL antibiotic-free normal growth medium supplemented with FBS and then incubated at 37°C in a 5% CO2 incubator for 24 hours. A total of 4 μL of 10 nmol/mL RRM2 or control siRNA was transfected into MDA-MB-231 or ZR-75-1 cells by using the transfection RNAiMAX reagent (Invitrogen, Carlsbad, CA). Cells were incubated in the transfection medium for 6 hours and then placed in normal cell culture medium. The inhibition of RRM2 and RRM2B was measured by using Western blot analysis.
For the invasion assay
[22 (link)], 2.5 × 104 cells were seeded on the Matrigel™ (BD company) insert of the 24-well chamber. After incubation for 72 hours in 5% CO2 at 37°C, the top of the Matrigel™ inserts were wiped with a cotton-tipped swab to remove cells that had not migrated through the membrane. The cells on the lower surface of the membrane were stained with 0.5% Coomassie blue (dissolved in 50% ethanol) and counted. Each experiment was performed three times.
Cytotoxicity was assessed using the MTS assay, according to the manufacturer’s instructions (CellTiter 96 AQueous Assay reagent; Promega) on 10 replicates of 2,500 cells per well in a 96-well plate treated with test drugs for 72 hours.
+ Open protocol
+ Expand
9

Cell Viability Assay Protocol for LC50 Determination

Check if the same lab product or an alternative is used in the 5 most similar protocols
For each compound, the LC 50 was determined using a MTS tetrazolium cell viability assay according to the manufacturer's instructions (CellTiter 96 AQueous Assay Reagent; Promega). Brie y, the CellTiter 96 AQueous One Solution Reagent was added to each well and incubated at 37°C for 3 hrs. Cell proliferation was determined by measuring the absorbance at 490 nm using a microtiter plate reader (Molecular Devices, Sunnyvale, CA). The LC 50 for each compound was obtained from the viability curves using GraphPad Prism 5 (Supplementary Table S1). Experiments were carried out in triplicate for each drug.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!